GRO Biosciences Inc. — Form D
GRO Biosciences Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-22. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-03-22
- Form: D
- Accession: 0001715412-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.7M
- Amount sold: $3.7M
- Investors: 10
- Date of first sale: 2019-03-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-335448
Issuer
- Name: GRO Biosciences Inc.
- CIK: 0001715412
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 750 Main Street, Cambridge, MA, 02139
- Phone: 415-999-7625
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Christopher Gregg | Director | Allston, MA |
| Daniel Mandell | Director | Allston, MA |
| Geoffrey Smith | Director | Palo Alto, CA |
| Daniel Mandell | Executive Officer | Allston, MA |
| Ming J Fang | Director | Cambridge, MA |
| Bruce J Beutel | Director | Cambridge, MA |
| Dan J Becker | Director | Cambridge, MA |
| Tracey J Lodie | Executive Officer | Cambridge, MA |
| Kevin J Bitterman | Director | Cambridge, MA |
| Daniel J Mandell | Director | Cambridge, MA |
| Daniel J Mandell | Executive Officer | Cambridge, MA |
| Rakhshita J Dhar | Director | Cambridge, MA |
| Christopher J Gregg | Director | Allston, MA |
| Geoffrey J Smith | Director | Allston, MA |
| Dainel Mandell | Director | Allston, MA |
| Dainel Mandell | Executive Officer | Allston, MA |
Other filings by this issuer (3)
More